Olmesartan Medoxomil Accord Healthcare Ireland

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil Accord Healthcare Ireland, is a angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension in adults and may be used as part of combination therapy. GNH USA supplies Olmesartan Medoxomil Accord Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxil Accord Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan medoxil is an angiotensin II receptor antagonist that lowers blood pressure by acting on the renin‑angiotensin system.

- Hypertension: helps lower systolic and diastolic blood pressure in adults. - Heart failure: used as an adjunct to other antihypertensives to reduce cardiac workload. - Diabetic nephropathy: may delay progression of kidney damage associated with type 2 diabetes. - Post‑myocardial infarction: contributes to long‑term blood‑pressure control after a heart attack. - Stroke prevention: assists in reducing the risk of recurrent stroke in patients with hypertension. - Chronic kidney disease: aids in blood‑pressure management for patients with CKD stages 1‑3.

Olmesartan medoxil may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness or light‑headed ​​(especially after the first dose). - Headache. - Fatigue. - Nasal congestion. - Diarrhoea. - Upper respiratory tract infection symptoms.

Serious or Rare Side Effects: - Angio‑edema involving the face, lips, tongue or airway. - Severe hypotension, particularly in volume‑depleted patients. - Acute kidney injury or worsening renal function. - Hyperkalemia (elevated blood potassium). - Liver enzyme elevations. - Allergic skin reactions such as Stevens‑Johnson syndrome.

Olmesartan medoxil should be used with caution in patients with certain medical conditions and under professional supervision.

- Monitor cardiovascular  :  t  t  t  ...   t  ...  ... ... ...  ...  ... ... ... ... ... ...  t …  -   t  t t -  

t " " ". -  . - " "  t "  -   -   t  t. -  t " \